Novel n-3 Docosapentaneoic Acid-Derived Pro-resolving Mediators Are Vasculoprotective and Mediate the Actions of Statins in Controlling Inflammation
Authors:
- 28 September 2019
- book chapter
- Published by Springer Nature
- Vol. 1161, 65-75
Abstract
Inflammation is a fundamentally protective process that guards the host from invading pathogens and is central in the repair and regeneration of damaged tissue. However, when uncontrolled, the overzealous response leads to tissue damage and malaise. Indeed, this process is now appreciated to be at the center of many chronic inflammatory diseases including vascular disease and arthritis. Studies investigating the mechanisms through which acute inflammation is actively turned off allowing tissues to regain function demonstrated that the essential fatty acids, arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are enzymatically converted to bioactive mediators. These autacoids carry distinct structures and biological actions, actively reprogramming the inflammatory reaction to promote its termination by counter-regulating the production of pro-inflammatory mediators and regulate leukocyte trafficking as well as phenotype. Recently we found that n-3 docosapentaenoic acid (DPA), which was until then only regarded as a biosynthetic intermediate in the formation of DHA from EPA, is also converted to structurally distinct bioactive mediators that reprogram the host immune response. In the present review we will discuss the evidence underpinning the biological actions of these novel n-3 DPA-derived autacoids in particular as they pertain to the vascular system.Keywords
This publication has 42 references indexed in Scilit:
- Novel n-3 Immunoresolvents: Structures and ActionsScientific Reports, 2013
- A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolutionProstaglandins, Leukotrienes and Essential Fatty Acids, 2013
- Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE ConsortiumPLOS Genetics, 2011
- n–3 Fatty Acids in Cardiovascular DiseaseNew England Journal of Medicine, 2011
- Is shift work a risk factor for rheumatoid arthritis? The Finnish Public Sector studyAnnals of the Rheumatic Diseases, 2010
- Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4Mucosal Immunology, 2010
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actionsJournal of Experimental Medicine, 2008
- Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and plateletsBlood, 2008
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- The Ancient Riddle of Formula (Sepsis)The Journal of Infectious Diseases, 1991